Business
Completion of Investment by Stratasys in Xaar 3D
Completion of Investment by Stratasys in Xaar 3D.
About this update from Xaar Plc
[{"type":"text","content":"\n \nRNS Number : 7187V Xaar PLC 04 December 2019 \n\n \nXaar plc (the \"Company\")\nCompletion of Investment by Stratasys in Xaar 3D Limited\n \nThe Company is pleased to announce that following the announcement of 27 November 2019, the proposed increase of investment by Stratasys in Xaar 3D with an option for Stratasys to acquire the whole of Xaar 3D within 3 years, has completed following receipt of funds. \n \n \nEnquiries:\n \n\n\n\nXaar plc\n\n\n\n\n\n\n\nJohn Mills, Chief Executive Officer\nShomit Kenkare, Chief Financial Officer\n\n\n+44 (0)1223 423 663 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJefferies International (Financial advisor and Sponsor)\n\n\n+44 (0)20 7029 8000\n\n\n\n\nMax Jones\n\n\n\n\n\n\n\nWill Soutar\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTulchan Communications\n\n\n+44 (0)20 7353 4200\n\n\n\n\nJames Macey White\n \n\n\n\n\n\n\n \n \nAbout XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and 3D Printing which use our inkjet technology.\n \nAbout Stratasys\nStratasys is a global leader in additive technology solutions for industries including Aerospace, Automotive, Healthcare, Consumer Products and Education. For nearly 30 years, a deep and ongoing focus on customers' business requirements has fueled purposeful innovations - 1,200 granted and pending additive technology patents to date - that create new value across product lifecycle processes, from design prototypes to manufacturing tools and final production parts.\n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END MSCBLBDDGUGBGCS\n ","length":5579,"tagName":"div"}]